Investor Presentaiton
Appendix 3: AFT Global product portfolio
AFT is building the global presence of its proprietary and patented products through its network of licensees and
distributors.
It continues the development of its portfolio of repurposed medicines: Maxigesic, Pascomer, NasoSURF, Crystawash
Extend and Crystaderm
Pain
Maxigesic oral dose forms – tablets, solution, hot drink sachet,
rapid, cold and flu
Maxigesic IV (intravenous)
Hospital
NasoSurf nasal nebuliser drug delivery
Dermatology
1 Paracetamol and Ibuprofen
AFTpharmaceuticals
Pascomer - primarily North America & Europe
Crystawash extend - selected territories such as Canada &
Middle East
Crystaderm - selected territories such as Canada
PHARMACIST ONLY MEDICINE
KRIP OUT OF BEAN OF CHILDREN
maxigesiC
1500mg+buprafen 180mg
pain and f
DOUBLE
ACTION
NAST #218705
maxigesiCIV
30 Film Coated Tablets
CUT OF REACH OF CHILDREN
PRESCRIPTION ONLY MEDICINE
maxigesIC IV
Paraceland 1001 my and buarakan (as sodiun dhytrase) 500mg in 100 mp
100 mL
Solution for Infusion
Forinated
10 x10) m. Valg AFT
CRYSTAWASI
EXTE
NASH
TEND
Sanitising Spr.CRYSTAWASH
EXTEND
Sanitiser
Sarities end prod
09.90% of
Long-sorg formu
Foaming
Hand Sanitiser
Sarees underco
27395
24
PRESCRIPTION ONLY MEDICI
maxigesic
belastun
10 HAND PULL HERE
Page 23View entire presentation